MENU

Johnson & Johnson beats sales estimates on pharma strength

The company tightened its full-year adjusted profit forecast range. Sales at its medical devices unit rose to $6.78 billion on demand for contact lenses and wound-closure products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story